Aditxt Engages IBN (InvestorBrandNetwork) To Bolster Its Corporate Communications Efforts
June 09, 2022 08:30 ET
|
InvestorBrandNetwork (IBN)
LOS ANGELES, June 09, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – Aditxt, Inc. (“Aditxt” or “the Company”) (NASDAQ: ADTX), a biotech innovation company, today announces it has selected the corporate...
Global Allergy Diagnostics Market Report 2022: Market to Reach US$5.7 Billion by 2026 - Increasing Prevalence and Incidence of Allergic Disorders to Drive the Demand
June 07, 2022 05:48 ET
|
Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Allergy Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Allergy Diagnostics...
Global Allergen Blocker Market Report to 2027 - Featuring Trutek, Prestige Brands and Ecology Works Among Others
June 07, 2022 04:53 ET
|
Research and Markets
Dublin, June 07, 2022 (GLOBE NEWSWIRE) -- The "Allergen Blocker Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027" report has been added to ResearchAndMarkets.com's...
AXIM Biotechnologies Completes Optimization of Only FDA-Cleared IgE Rapid Diagnostics Test – In-House Manufacturing Lowers Cost and Eliminates Supply Chain Expenditures
May 24, 2022 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, May 24, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting ocular surface...
Worldwide Allergy Immunotherapy Industry to 2028 - Increasing Approval of Allergy Immunotherapy by Regulatory Authorities are Driving Growth
April 28, 2022 07:23 ET
|
Research and Markets
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Allergy Immunotherapy Market, by Treatment Type, by Allergy Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity...
Prebiotic and Probiotic Synergy with Pro+ Synbiotic Supports Allergy Relief Through Balanced Gut Health
April 27, 2022 09:10 ET
|
Wakunaga of America: Kyo-Dophilus Probiotics
MISSION VIEJO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Seasonal allergy sufferers will try just about anything to reduce the discomforts associated with the change of the seasons from winter to...
AAFA Asks Congress to Act on the Growing Asthma and Allergy Burden on Individuals and Communities
April 26, 2022 10:44 ET
|
Asthma and Allergy Foundation of America
Washington, D.C., April 26, 2022 (GLOBE NEWSWIRE) -- Patient advocates and leadership from the Asthma and Allergy Foundation of America (AAFA) appeal to U.S. representatives and senators to act on...
Asthma Foundation Urges President Biden to Act As Asthma Deaths Rise
March 31, 2022 13:56 ET
|
Asthma and Allergy Foundation of America
Washington, D.C., March 31, 2022 (GLOBE NEWSWIRE) -- Today, the Asthma and Allergy Foundation of America (AAFA) requested President Biden to proclaim May as “National Asthma and Allergy Awareness...
Global Deoxyribonucleic Acid (DNA) Vaccines Market Size to Reach USD 11.43 Billion by 2028; Rising Cases of Cancer Patients & Infectious Diseases is Expected to Drive the Deoxyribonucleic Acid (DNA) Vaccines Market - Vantage Market Research
March 07, 2022 05:26 ET
|
Vantage Market Research
WASHINGTON, March 07, 2022 (GLOBE NEWSWIRE) -- Vaccinations are majorly used for protecting against infectious agents or components of infectious agents. In recent years radically a new approach has...
Asthma and Allergy Foundation of America Announces 2022 Allergy Capitals
March 02, 2022 07:00 ET
|
Asthma and Allergy Foundation of America
Washington D.C., March 02, 2022 (GLOBE NEWSWIRE) -- Today, the Asthma and Allergy Foundation of America (AAFA) released its annual Allergy Capitals™ report for 2022. The report identifies the most...